Sofia Galinaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Sofia Galinaki has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Dimitrios Tsiptsios
3rd Department of Neurology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
1 shared publication - Emmanouil Rizos
Second Department of Psychiatry, “Attikon” University General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece
1 shared publication - Evangelia Kollintza
Second Department of Psychiatry, Attikon University General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece
1 shared publication - Evangelos Alevyzakis
Second Department of Psychiatry, “Attikon” University General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece
1 shared publication - Ioannis Hortis
Second Department of Psychiatry, Attikon University General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece
1 shared publication - Konstantinos Triantafyllou
General University Hospital Attikon, Greece
1 shared publication
Latest Publications
- Open Access
- 29 May 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (6) , 1121
Gut Microbiome: A Brief Review on Its Role in Schizophrenia and First Episode of Psychosis
There is a growing body of evidence highlighting the role of gut microbiota as a biological basis of psychiatric disorders. The existing literature suggest that cognitive and emotional activities can be influenced by microbes through the microbiota–gut–brain axis and implies an association between alterations in the gut microbiome and several psychiatric conditions, such as autism, depression, bipolar disorder and psychosis. The aim of this review is to summarise recent findings and provide concise updates on the latest progress of the role of gut microbiota in the development and maintenance of psychiatric symptoms in schizophrenia and the first episode of psychosis. Despite the lack of consistent findings in regard to specific microbiome changes related to psychosis, the emerging literature reports significant differences in the gut microbiome of schizophrenic subjects compared to healthy controls and increasingly outlines the significance of an altered microbiome composition in the pathogenesis, development, symptom severity and prognosis of psychosis. Further human studies are, however, required, which should focus on identifying the drivers of microbiota changes in psychosis and establish the direction of causality between psychosis and microbiome alterations.
- 29 May 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (6) , 1121
Open AccessGut Microbiome: A Brief Review on Its Role in Schizophrenia and First Episode of Psychosis
There is a growing body of evidence highlighting the role of gut microbiota as a biological basis of psychiatric disorders. The existing literature suggest that cognitive and emotional activities can be influenced by microbes through the microbiota–gut–brain axis and implies an association between alterations in the gut microbiome and several psychiatric conditions, such as autism, depression, bipolar disorder and psychosis. The aim of this review is to summarise recent findings and provide concise updates on the latest progress of the role of gut microbiota in the development and maintenance of psychiatric symptoms in schizophrenia and the first episode of psychosis. Despite the lack of consistent findings in regard to specific microbiome changes related to psychosis, the emerging literature reports significant differences in the gut microbiome of schizophrenic subjects compared to healthy controls and increasingly outlines the significance of an altered microbiome composition in the pathogenesis, development, symptom severity and prognosis of psychosis. Further human studies are, however, required, which should focus on identifying the drivers of microbiota changes in psychosis and establish the direction of causality between psychosis and microbiome alterations.